A Compendium of Co-regulated Protein Complexes in Breast Cancer Reveals Collateral Loss Events

od Ryan, Colm J., Kennedy, Susan, Bajrami, Ilirjana, Matallanas, David, Lord, Christopher J.
Wydane w Cell Syst (2017)

APRIN is a cell cycle specific BRCA2-interacting protein required for genome integrity and a predictor of outcome after chemotherapy in breast cancer

od Brough, Rachel, Bajrami, Ilirjana, Vatcheva, Radost, Natrajan, Rachael, Reis-Filho, Jorge S, Lord, Christopher J, Ashworth, Alan
Wydane 2012

Synthetic lethality of PARP and NAMPT inhibition in triple-negative breast cancer cells

od Bajrami, Ilirjana, Kigozi, Asha, Van Weverwijk, Antoinette, Brough, Rachel, Frankum, Jessica, Lord, Christopher J, Ashworth, Alan
Wydane 2012

Functional genetic screen identifies increased sensitivity to WEE1 inhibition in cells with defects in Fanconi Anaemia and HR pathways

od Aarts, Marieke, Bajrami, Ilirjana, Herrera-Abreu, Maria Teresa, Elliott, Richard, Brough, Rachel, Ashworth, Alan, Lord, Christopher J., Turner, Nicholas C.
Wydane w Mol Cancer Ther (2015)

BMN 673, a novel and highly potent PARP1/2 inhibitor for the treatment of human cancers with DNA repair deficiency

od Shen, Yuqiao, Rehman, Farah L, Feng, Ying, Boshuizen, Julia, Bajrami, Ilirjana, Elliott, Richard, Wang, Bing, Lord, Christopher J., Post, Leonard E., Ashworth, Alan
Wydane w Clin Cancer Res (2013)

A Genetic Screen Using the PiggyBac Transposon in Haploid Cells Identifies Parp1 as a Mediator of Olaparib Toxicity

od Pettitt, Stephen J., Rehman, Farah L., Bajrami, Ilirjana, Brough, Rachel, Wallberg, Fredrik, Kozarewa, Iwanka, Fenwick, Kerry, Assiotis, Ioannis, Chen, Lina, Campbell, James, Lord, Christopher J., Ashworth, Alan
Wydane 2013

Targeting the nucleotide salvage factor DNPH1 sensitizes BRCA-deficient cells to PARP inhibitors

od Fugger, Kasper, Bajrami, Ilirjana, Silva Dos Santos, Mariana, Young, Sarah Jane, Kunzelmann, Simone, Kelly, Geoff, Hewitt, Graeme, Patel, Harshil, Goldstone, Robert, Carell, Thomas, Boulton, Simon J., MacRae, James, Taylor, Ian A., West, Stephen C.
Wydane w Science (2021)

Genome-wide profiling of genetic synthetic lethality identifies CDK12 as a novel determinant of PARP1/2 inhibitor sensitivity

od Bajrami, Ilirjana, Frankum, Jessica R., Konde, Asha, Miller, Rowan E., Rehman, Farah L., Brough, Rachel, Campbell, James, Sims, David, Rafiq, Rumana, Hooper, Sean, Chen, Lina, Kozarewa, Iwanka, Assiotis, Ioannis, Fenwick, Kerry, Natrajan, Rachael, Lord, Christopher J., Ashworth, Alan
Wydane w Cancer Res (2013)

Histone H3.3 mutations drive paediatric glioblastoma through upregulation of MYCN

od Bjerke, Lynn, Mackay, Alan, Nandhabalan, Meera, Burford, Anna, Jury, Alexa, Popov, Sergey, Bax, Dorine A, Carvalho, Diana, Taylor, Kathryn R, Vinci, Maria, Bajrami, Ilirjana, McGonnell, Imelda M, Lord, Christopher J, Reis, Rui M, Hargrave, Darren, Ashworth, Alan, Workman, Paul, Jones, Chris
Wydane 2013

Genome-wide barcoded transposon screen for cancer drug sensitivity in haploid mouse embryonic stem cells

od Pettitt, Stephen J., Krastev, Dragomir B., Pemberton, Helen N., Fontebasso, Yari, Frankum, Jessica, Rehman, Farah L., Brough, Rachel, Song, Feifei, Bajrami, Ilirjana, Rafiq, Rumana, Wallberg, Fredrik, Kozarewa, Iwanka, Fenwick, Kerry, Armisen-Garrido, Javier, Swain, Amanda, Gulati, Aditi, Campbell, James, Ashworth, Alan, Lord, Christopher J.
Wydane w Sci Data (2017)

Functional Viability Profiles of Breast Cancer

od Brough, Rachel, Frankum, Jessica R., Sims, David, Mackay, Alan, Mendes-Pereira, Ana M., Bajrami, Ilirjana, Costa-Cabral, Sara, Rafiq, Rumana, Ahmad, Amar S., Cerone, Maria Antonietta, Natrajan, Rachael, Sharpe, Rachel, Shiu, Kai-Keen, Wetterskog, Daniel, Dedes, Konstantine J., Lambros, Maryou B., Rawjee, Teeara, Linardopoulos, Spiros, Reis-Filho, Jorge S., Turner, Nicholas C., Lord, Christopher J., Ashworth, Alan
Wydane 2011

Large-Scale Profiling of Kinase Dependencies in Cancer Cell Lines

od Campbell, James, Ryan, Colm J., Brough, Rachel, Bajrami, Ilirjana, Pemberton, Helen N., Chong, Irene Y., Costa-Cabral, Sara, Frankum, Jessica, Gulati, Aditi, Holme, Harriet, Miller, Rowan, Postel-Vinay, Sophie, Rafiq, Rumana, Wei, Wenbin, Williamson, Chris T., Quigley, David A., Tym, Joe, Al-Lazikani, Bissan, Fenton, Timothy, Natrajan, Rachael, Strauss, Sandra J., Ashworth, Alan, Lord, Christopher J.
Wydane w Cell Rep (2016)

PARP inhibition enhances tumor cell–intrinsic immunity in ERCC1-deficient non–small cell lung cancer

od Chabanon, Roman M., Muirhead, Gareth, Krastev, Dragomir B., Adam, Julien, Morel, Daphné, Garrido, Marlène, Lamb, Andrew, Hénon, Clémence, Dorvault, Nicolas, Rouanne, Mathieu, Marlow, Rebecca, Bajrami, Ilirjana, Cardeñosa, Marta Llorca, Konde, Asha, Besse, Benjamin, Ashworth, Alan, Pettitt, Stephen J., Haider, Syed, Marabelle, Aurélien, Tutt, Andrew N.J., Soria, Jean-Charles, Lord, Christopher J., Postel-Vinay, Sophie
Wydane w J Clin Invest (2019)

Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast

od Natrajan, Rachael, Wilkerson, Paul M, Marchiò, Caterina, Piscuoglio, Salvatore, Ng, Charlotte KY, Wai, Patty, Lambros, Maryou B, Samartzis, Eleftherios P, Dedes, Konstantin J, Frankum, Jessica, Bajrami, Ilirjana, Kopec, Alicja, Mackay, Alan, A'hern, Roger, Fenwick, Kerry, Kozarewa, Iwanka, Hakas, Jarle, Mitsopoulos, Costas, Hardisson, David, Lord, Christopher J, Kumar-Sinha, Chandan, Ashworth, Alan, Weigelt, Britta, Sapino, Anna, Chinnaiyan, Arul M, Maher, Christopher A, Reis-Filho, Jorge S
Wydane 2014

Chemosensitivity profiling of osteosarcoma tumour cell lines identifies a model of BRCAness

od Holme, Harriett, Gulati, Aditi, Brough, Rachel, Fleuren, Emmy D. G., Bajrami, Ilirjana, Campbell, James, Chong, Irene Y., Costa-Cabral, Sara, Elliott, Richard, Fenton, Tim, Frankum, Jessica, Jones, Samuel E., Menon, Malini, Miller, Rowan, Pemberton, Helen N., Postel-Vinay, Sophie, Rafiq, Rumana, Selfe, Joanna L., von Kriegsheim, Alex, Munoz, Amaya Garcia, Rodriguez, Javier, Shipley, Janet, van der Graaf, Winette T. A., Williamson, Chris T., Ryan, Colm J., Pettitt, Stephen, Ashworth, Alan, Strauss, Sandra J., Lord, Christopher J.
Wydane w Sci Rep (2018)

Author Correction: Chemosensitivity profiling of osteosarcoma tumour cell lines identifies a model of BRCAness

od Holme, Harriett, Gulati, Aditi, Brough, Rachel, Fleuren, Emmy D. G., Bajrami, Ilirjana, Campbell, James, Chong, Irene Y., Costa-Cabral, Sara, Elliott, Richard, Fenton, Tim, Frankum, Jessica, Jones, Samuel E., Menon, Malini, Miller, Rowan, Pemberton, Helen N., Postel-Vinay, Sophie, Rafiq, Rumana, Selfe, Joanna L., von Kriegsheim, Alex, Munoz, Amaya Garcia, Rodriguez, Javier, Shipley, Janet, van der Graaf, Winette T. A., Williamson, Chris T., Ryan, Colm J., Pettitt, Stephen, Ashworth, Alan, Strauss, Sandra J., Lord, Christopher J.
Wydane w Sci Rep (2018)

E-cadherin/ROS1 inhibitor synthetic lethality in breast cancer

od Bajrami, Ilirjana, Marlow, Rebecca, van de Ven, Marieke, Brough, Rachel, Pemberton, Helen N., Frankum, Jessica, Song, Fei Fei, Rafiq, Rumana, Konde, Asha, Krastev, Dragomir B., Menon, Malini, Campbell, James, Gulati, Aditi, Kumar, Rahul, Pettitt, Stephen J., Gurden, Mark D., Cardenosa, Marta Llorca, Chong, Irene, Gazinska, Patrycja, Wallberg, Fredrik, Sawyer, Elinor J., Martin, Lesley-Ann, Dowsett, Mitch, Linardopoulos, Spiros, Natrajan, Rachael, Ryan, Colm J., Derksen, Patrick W.B., Jonkers, Jos, Tutt, Andrew N.J., Ashworth, Alan, Lord, Christopher J.
Wydane w Cancer Discov (2018)

Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer

od Dreyer, Stephan B., Upstill-Goddard, Rosie, Paulus-Hock, Viola, Paris, Clara, Lampraki, Eirini-Maria, Dray, Eloise, Serrels, Bryan, Caligiuri, Giuseppina, Rebus, Selma, Plenker, Dennis, Galluzzo, Zachary, Brunton, Holly, Cunningham, Richard, Tesson, Mathias, Nourse, Craig, Bailey, Ulla-Maja, Jones, Marc, Moran-Jones, Kim, Wright, Derek W., Duthie, Fraser, Oien, Karin, Evers, Lisa, McKay, Colin J., McGregor, Grant A., Gulati, Aditi, Brough, Rachel, Bajrami, Ilirjana, Pettitt, Stephan, Dziubinski, Michele L., Candido, Juliana, Balkwill, Frances, Barry, Simon T., Grützmann, Robert, Rahib, Lola, Johns, Amber, Pajic, Marina, Froeling, Fieke E.M., Beer, Phillip, Musgrove, Elizabeth A., Petersen, Gloria M., Ashworth, Alan, Frame, Margaret C., Crawford, Howard C., Simeone, Diane M., Lord, Chris, Mukhopadhyay, Debabrata, Pilarsky, Christian, Tuveson, David A., Cooke, Susanna L., Jamieson, Nigel B., Morton, Jennifer P., Sansom, Owen J., Bailey, Peter J., Biankin, Andrew V., Chang, David K.
Wydane w Gastroenterology (2021)

Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer

od Ruark, Elise, Snape, Katie, Humburg, Peter, Loveday, Chey, Bajrami, Ilirjana, Brough, Rachel, Rodrigues, Daniel Nava, Renwick, Anthony, Seal, Sheila, Ramsay, Emma, Duarte, Silvana Del Vecchio, Rivas, Manuel A., Warren-Perry, Margaret, Zachariou, Anna, Campion-Flora, Adriana, Hanks, Sandra, Murray, Anne, Pour, Naser Ansari, Douglas, Jenny, Gregory, Lorna, Rimmer, Andrew, Walker, Neil M., Yang, Tsun-Po, Adlard, Julian W., Barwell, Julian, Berg, Jonathan, Brady, Angela F., Brewer, Carole, Brice, Glen, Chapman, Cyril, Cook, Jackie, Davidson, Rosemarie, Donaldson, Alan, Douglas, Fiona, Eccles, Diana, Evans, D. Gareth, Greenhalgh, Lynn, Henderson, Alex, Izatt, Louise, Kumar, Ajith, Lalloo, Fiona, Miedzybrodzka, Zosia, Morrison, Patrick J., Paterson, Joan, Porteous, Mary, Rogers, Mark T., Shanley, Susan, Walker, Lisa, Gore, Martin, Houlston, Richard, Brown, Matthew A., Caufield, Mark J., Deloukas, Panagiotis, McCarthy, Mark I., Todd, John A., Turnbull, Clare, Reis-Filho, Jorge S., Ashworth, Alan, Antoniou, Antonis C., Lord, Christopher J., Donnelly, Peter, Rahman, Nazneen
Wydane 2012